Breast-cancer screening--viewpoint of the IARC Working Group.
about
Cancer prevention as part of precision medicine: 'plenty to be done'Utility of supplemental screening with breast ultrasound in asymptomatic women with dense breast tissue who are not at high risk for breast cancerPosition paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, FraOn a fractional order calculus model in diffusion weighted breast imaging to differentiate between malignant and benign breast lesions detected on X-ray screening mammography.Breast Cancer Screening Programmes across the WHO European Region: Differences among Countries Based on National Income LevelExamining screening mammography participation among women aged 40 to 74.What determines the effects and costs of breast cancer screening? A protocol of a systematic review of reviewsMe, TooScreening by Clinical Breast Examination in Western Kenya: Who Comes?Targeting breast cancer outcomes-what about the primary relatives?The Outcome of Breast Cancer Is Associated with National Human Development Index and Health System AttainmentHas screening mammography become obsolete?Breast cancer screening panels continue to confuse the facts and inject their own biasesResponse to: "Beyond the mammography debate: a moderate perspective".Prediction of malignancy by a radiomic signature from contrast agent-free diffusion MRI in suspicious breast lesions found on screening mammography.Investigating young women's motivations to engage in early mammography screening in Switzerland: results of a cross-sectional studyHigh sensitivity non-invasive detection of calcifications deep inside biological tissue using Transmission Raman Spectroscopy.Women's Expectations for Breast Cancer Prevention and Early Detection: High Expectations Can Be Achieved.Response to: "[Miller's] Response to: 'Beyond the mammography debate: a moderate perspective'".Risk of breast cancer after false-positive results in mammographic screening.Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment.Impact of organised mammography screening on breast cancer mortality in a case-control and cohort study.Cumulative risk of false positive test in relation to breast symptoms in mammography screening: a historical prospective cohort study.Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer.Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.Life-course socioeconomic status and breast and cervical cancer screening: analysis of the WHO's Study on Global Ageing and Adult Health (SAGE).The Impact of Rurality and Disadvantage on the Diagnostic Interval for Breast Cancer in a Large Population-Based Study of 3202 Women in Queensland, Australia.Preliminary effectiveness of breast cancer screening among 1.22 million Chinese females and different cancer patterns between urban and rural women.Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies.Non-invasive optical estimate of tissue composition to differentiate malignant from benign breast lesions: A pilot study.Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort studyMammography: an update of the EUSOBI recommendations on information for women.Synergy in combining findings from mammography and ultrasonography in detecting malignancy in women with higher density breasts and lesions over 2 cm in Albania.Overdiagnosis of breast cancer in population screening: does it make breast screening worthless?The effect of population-based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow-up.Integrated gene expression profiling and chromatin immunoprecipitation followed by sequencing: Analysis of the C-terminal binding protein in breast cancer.The personal cancer screening behaviours of nurses and midwives.Cumulative risk of breast cancer screening outcomes according to the presence of previous benign breast disease and family history of breast cancer: supporting personalised screening.The Japanese Guidelines for Breast Cancer Screening.
P2860
Q26995183-552A203E-7792-4617-AD90-4AD37BCCBBC5Q30356114-86557427-405D-4B65-ABFE-BA5DB6CC422FQ32186742-D2F49A95-096F-4AAF-B5B0-B9A30D1C20BAQ33615009-7C4AD813-7CE8-448A-9B79-23054F2522B1Q33616505-6E081092-D110-41FB-B597-B786310B7440Q33798948-97833CF3-6668-4BC3-AD93-1035710C02CAQ33850892-2EDF68BD-EB13-485B-9A20-642ED35B0480Q33866095-12A335E4-18BC-4CF0-B5F4-4A1A3BE43159Q33866101-3383E469-567A-4605-BD7B-B02A05C259B1Q33906971-D1D6A05E-D5D0-4884-8FE4-AC900242ABC9Q36070933-40C33D85-242C-4461-B746-404401968781Q36169845-F7ADBDBD-E714-472A-875A-BF8CB3B0C5F1Q36169896-D2276B6F-8F1E-43D3-9CBD-9645E66B6185Q36169940-2A6F3119-B537-44E2-A70B-40E31E0B65D8Q36268031-5F486833-F829-475B-8F79-1D96FCC47EDFQ36317338-A9784C2F-9108-4E19-B654-E1D374A26076Q36411029-56BFBAB8-2DCF-4C5B-8315-D38711EB6F52Q36452292-E1304504-DA2E-47B7-A822-8B652EDA034BQ36989170-86BCE8D5-6251-4957-8FE5-8133CFAB5CA1Q37045604-7F0E6FCC-BAB2-4031-B828-9CABE592257AQ37101470-8EA84D5C-A1F0-44B1-9BCC-1E5B7CA0929AQ37175075-01F81ACB-2430-44A5-9F9D-0A8DB57E768AQ37233803-E186F819-7AB5-4EE5-9DBF-97817DD0FC78Q37364628-F693A2AA-F750-4223-AFAA-C55EA25BBEACQ37437368-8B89333F-7795-4376-B28F-62CA9213A2D7Q37444608-11CC678A-FB02-42B7-8179-864ED343E2D7Q37454769-8B580BA8-2CDD-4088-87EB-4C6259CF2094Q37455963-94259EF3-AD1E-4A0D-9D96-17AEB2BA2B8BQ37518557-7801839A-584C-4B7A-814D-6458AB84A428Q37524981-9256192A-D602-49FC-A456-182B19D4F229Q37587664-689E5853-3319-4F09-9D35-2FAA110080F3Q37592886-18F63B46-F8F5-4E68-A2A8-DE7D279655DCQ37605271-87011881-8D25-4550-AE19-53EC3ADC41B4Q37657675-A64CF259-99DB-43A3-98EC-215DA02316B8Q37720423-2CAA3C5D-4893-4323-9987-890609D5940EQ38401279-BBDEC8E0-CB63-49D5-85D4-6F5F821B5ECFQ38432481-8DE93581-3C5C-416B-9016-D57625224874Q38791687-0B769E2C-D030-4015-9262-AC73F8276F05Q38828351-DB2BDC82-41CB-458F-A929-AAA9FA66F042Q38840507-75CF42E5-FF6A-4A9F-B81B-007A14F865EF
P2860
Breast-cancer screening--viewpoint of the IARC Working Group.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Breast-cancer screening--viewpoint of the IARC Working Group.
@en
type
label
Breast-cancer screening--viewpoint of the IARC Working Group.
@en
altLabel
Breast-Cancer Screening — Viewpoint of the IARC Working Group
@en
prefLabel
Breast-cancer screening--viewpoint of the IARC Working Group.
@en
P2093
P50
P356
P1476
Breast-cancer screening--viewpoint of the IARC Working Group.
@en
P2093
Chiara Scoccianti
Franca Bianchini
International Agency for Research on Cancer Handbook Working Group
P304
P356
10.1056/NEJMSR1504363
P407
P577
2015-06-03T00:00:00Z